All Q4 FY25 results →
C(

Colgate-Palmolive (India) Ltd

Q4 FY25Personal Products

Colgate-Palmolive (India) Q4 FY25 earnings call: Revenue & Margins

Q4 FY25 earnings call: what management guided on revenue, margins and order book.

Price₹1,889
Market cap₹55.5K Cr
P/E40.5
Updated23 Aug 2026
Read4 min read

The short version

Volume growth was flat in the last quarter, with slightly negative pricing contributing to it. The company's strategy focuses on driving category consumption, growing the core business, and building through science-backed premiumization. - Earnings per share (EPS) has shown growth, reaching Rs.

From Colgate-Palmolive (India) Ltd's Q4 FY25 earnings-call transcript · updated 23 Aug 2026.

Revenue & Sales Performance

  • Volume growth was flat in the last quarter, with slightly negative pricing contributing to it.
  • Management aims to drive top-line growth through both volume and value while managing pricing carefully.
  • Premiumization is expected to grow at around 4x the rest of the portfolio's growth, accelerating over the coming years.
  • Trade investments, especially in general trade which makes up three-quarters of the market, will continue to support growth.
  • Growth in rural markets remains resilient and outpaces urban growth, expected to continue positively.
  • The bottom 70% of urban India faces pressure currently, but this is viewed as temporary with expectations of sequential improvement, especially in the second half of the year.

2 more points from Colgate-Palmolive (India) Ltd's call on revenue

Pro opens every point from 15K+ earnings calls

Profitability & Margins

See what Colgate-Palmolive (India) Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

  • The transcript does not explicitly mention any current or future capex or capital investments.
  • Focus is primarily on brand investments, with Rs. 822 crores spent on the Colgate brand in FY 2024-25.
  • Emphasis on driving superior products, product quality enhancements (e.g., relaunch of Strong Teeth, Max Fresh).
  • Significant investments in trade and consumer spends to stay competitive.
  • No specific details on plant expansions, new factories, or large capital projects are provided.

2 more points from Colgate-Palmolive (India) Ltd's call on capex

Pro opens every point from 15K+ earnings calls

Top-ranked in Personal Products

Ranked on what management guided this quarter

Guidance-ranked
1Anondita Medi.
Rev 1Mar 1
Rev 2Mar 2
3
Rev 3Mar 3
4
Rev 3Mar 3
5
Rev 3Mar 3
Sign up free to see 3 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

See what Colgate-Palmolive (India) Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

The provided pages from the Colgate-Palmolive (India) Limited May 22, 2025 transcript do not mention any information regarding the current or expected order book or pending orders. The discussion primarily focuses on: - Brand strength and consumer buying behavior. - Market dynamics including premiumization and competition. - Financial performance including revenue, margins, and advertising spends.

2 more points from Colgate-Palmolive (India) Ltd's call on order book

Pro opens every point from 15K+ earnings calls

Colgate-Palmolive (India) Ltd — Quarterly revenue & net profit

Revenue Net profit
Dec 2024Q3 FY25
Mar 2025Q4 FY25
Jun 2025Q1 FY26
Sep 2025Q2 FY26
Dec 2025Q3 FY26
Mar 2026Q4 FY26

Reported quarterly figures (₹ Cr). Latest (Q4 FY26): revenue ₹1.6K Cr, net profit ₹353 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

Others in Personal Products this season

  • Cupid (Q4 FY25)

    125 crores by FY26, indicating +150% growth (Page 29, 18). Key concall takeaways from Cupid Ltd's Q4 FY25 earnings call — and how it ranks against sector peers.

  • P & G Hygiene (Q4 FY25)

    Feminine care category has substantial runway as penetration is under 50%, with market leadership maintained and growth driven by product upgrades and…

  • Gillette India (Q4 FY25)

    Gillette India delivered a 12% sales growth and 40% profit growth in the past year, reflecting strong execution of their Integrated Growth Strategy. Key…

  • Emami Ltd (Q4 FY25)

    Dividend payouts were highlighted, with a total dividend of 1000% or Rs. Key concall takeaways from Emami Ltd's Q4 FY25 earnings call — and how it ranks…

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Arthneeti Pro · Annual

Colgate-Palmolive (India) Ltd and 15K+ more earnings calls,
for less than your morning chai

a day

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access

Frequently Asked Questions

What were Colgate-Palmolive (India) Ltd Q4 FY25 results?

Volume growth was flat in the last quarter, with slightly negative pricing contributing to it. The company's strategy focuses on driving category consumption, growing the core business, and building through science-backed premiumization. - Earnings per share (EPS) has shown growth, reaching Rs.

What is Colgate-Palmolive (India) Ltd share price analysis?

Colgate-Palmolive (India) Ltd currently shows a neutral. The stock trades at a P/E of 40.5 with a market cap of ₹55,485 Cr. Investors should review the full earnings analysis for detailed insights.

Is Colgate-Palmolive (India) Ltd planning capital expenditure?

The transcript does not explicitly mention any current or future capex or capital investments. - Focus is primarily on brand investments, with Rs.

Keep Colgate-Palmolive (India) Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.